Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1708 ARTÍCULOS , VIENDO DEL 1636 AL 1650

Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases

Lindestam Arlehamn CS, Garretti F, Sulzer D, Sette A.

Curr Opin Immunol. 2019 Aug;59:115-120. doi: 10.1016/j.coi.2019.07.004. Epub 2019 Aug 17.

Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease

Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R.

J Neural Transm (Vienna). 2019 Nov;126(11):1437-1445. doi: 10.1007/s00702-019-02065-1. Epub 2019 Aug 20.

Early mechanisms of amyloid fibril nucleation in model and disease-related proteins

Morel B, Conejero-Lara F.

Biochim Biophys Acta Proteins Proteom. 2019 Nov;1867(11):140264. doi: 10.1016/j.bbapap.2019.140264. Epub 2019 Aug 19.

Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies

Smith C, Malek N, Grosset K, Cullen B, Gentleman S, Grosset DG.

J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1234-1243. doi: 10.1136/jnnp-2019-321111. Epub 2019 Aug 23.

Cardiovascular Disease, Diabetes Mellitus, and Hypertension in Lewy Body Disease: A Comparison with Other Dementia Disorders

Javanshiri K, Haglund M, Englund E.

J Alzheimers Dis. 2019;71(3):851-859. doi: 10.3233/JAD-190485.

Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases

Mathew B, Parambi DGT, Mathew GE, Uddin MS, Inasu ST, Kim H, Marathakam A, Unnikrishnan MK, Carradori S.

Arch Pharm (Weinheim). 2019 Nov;352(11):e1900177. doi: 10.1002/ardp.201900177. Epub 2019 Sep 3.

Olfactory dysfunction in the pathophysiological continuum of dementia

Bathini P, Brai E, Auber LA.

Ageing Res Rev. 2019 Nov;55:100956. doi: 10.1016/j.arr.2019.100956. Epub 2019 Aug 31.

Neurosteroids as regulators of neuroinflammation

Yilmaz C, Karali K, Fodelianaki G, Gravanis A, Chavakis T, Charalampopoulos I, Alexaki VI.

Front Neuroendocrinol. 2019 Oct;55:100788. doi: 10.1016/j.yfrne.2019.100788. Epub 2019 Sep 9.

Intrinsically disordered proteins in various hypotheses on the pathogenesis of Alzheimer's and Parkinson's diseases

Coskuner O, Uversky VN.

Prog Mol Biol Transl Sci. 2019;166:145-223. doi: 10.1016/bs.pmbts.2019.05.007. Epub 2019 Jul 19.

New Insights on the Role of Manganese in Alzheimer's Disease and Parkinson's Disease

Martins AC Jr, Morcillo P, Ijomone OM, Venkataramani V, Harrison FE, Lee E, Bowman AB, Aschner M.

Int J Environ Res Public Health. 2019 Sep 22;16(19):3546. doi: 10.3390/ijerph16193546.

Natural Products as Modulators of the Proteostasis Machinery: Implications in Neurodegenerative Diseases

Cuanalo-Contreras K, Moreno-Gonzalez I.

Int J Mol Sci. 2019 Sep 20;20(19):4666. doi: 10.3390/ijms20194666.

Microbiome Influence in the Pathogenesis of Prion and Alzheimer's Diseases

D'Argenio V, Sarnataro D.

Int J Mol Sci. 2019 Sep 23;20(19):4704. doi: 10.3390/ijms20194704.

Association between autophagy and rapid eye movement sleep loss-associated neurodegenerative and patho-physio-behavioral changes

Chauhan AK, Mallick BN.

Sleep Med. 2019 Nov;63:29-37. doi: 10.1016/j.sleep.2019.04.019. Epub 2019 Jun 1.

Treatment of Neurodegeneration: Integrating Photobiomodulation and Neurofeedback in Alzheimer's Dementia and Parkinson's: A Review

Berman MH, Nichols TW.

Photobiomodul Photomed Laser Surg. 2019 Oct;37(10):623-634. doi: 10.1089/photob.2019.4685.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias